Faculty

Institution

Unit

Venue

Michelle Loch

Louisiana State University Health Sciences Center, New Orleans

Affiliations

School of Medicine

Division of Hematology & Oncology

NoneMichelle Loch is currently serving as a Division Of Hematology & Oncology faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michelle Loch

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

oncology cancer care breast cancer medicine breast oncology cancer research radiation oncology women's health health sciences cancer treatment pharmacology clinical research surgical oncology gynecologic oncology tumor biology cancer imaging molecular cancer medicinal research cancer discovery cancer management hematology pharmacotherapy women's studies cancer biology leukemia anti-cancer agents cancer risk cancer detection epidemiology of cancer clinical evidence tumor targeting covid-19 pandemic patient-reported outcomes adjuvant endocrine therapy overall survival cardiology thrombosis jama oncology ethnic studies brain tumor research vascular biology canadian studies radiation therapy treatment and prevention cancer education ethnic discrimination disparate impact tumor heterogeneity cancer registration cohort studies disease progression prospective cohort studies retrospective cohort studies endocrine oncology endocrine-related cancers cancer screening diabetes mellitus diabetes management metabolic disorders epidemiological outcome disease risk assessment disease assessment caplacizumab therapy thrombotic thrombocytopenic purpura clinical implications seer data ten national program cancer registries states patient-derived xenografts cancer subtypes guideline-concordant adjuvant therapy population-based study circulating tumor dna dna monitoring high risk individuals gynecological cancers

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract P1-10-19: Hypophysitis and Haziness in Her2: A Case of Breast Cancer With Leptomeningeal Carcinomatosis. Clinical Cancer Research (2025)

pathologyleptomeningeal carcinomatosisgynecologyabstract p1-10-19breast cancer

Abstract P4-03-06: A Single-Center Review of the Impact of an Integrated Women’s Health Clinic for Breast Cancer Patients Who Received Cancer-Directed Treatment. Clinical Cancer Research (2025)

breast oncologygynecologic oncologywomen's healthhealth clinicgynecologybreast cancer patientsnursingsingle-center reviewcancer managementcancer careoncologybreast cancer

Abstract P5-03-10: Safety and Preliminary Efficacy of Tucatinib and Alpelisib in Patients With Her2-Positive Pik3Ca-Mutated Metastatic Breast Cancer. Clinical Cancer Research (2025)

breast oncologyoncogenesmetastasisradiation oncologypreliminary efficacymolecular cancerabstract p5-03-10pharmacologycancer treatmentcancer careoncologybreast cancer

Circulating Tumor (Ct)Dna Monitoring of Er+/Her2- High-Risk Breast Cancer During Adjuvant Endocrine Therapy.. Journal of Clinical Oncology (2025)

breast oncologypathologyendocrine-related cancersadjuvant endocrine therapyradiologycancer imagingcancer detectiondna monitoringcancer cellscancer treatmentcancer careoncologybreast cancer

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women. JAMA Oncology (2025)

postreproductive healthneuroscience of agingpsychiatryendocrine therapywomen's healthmenopause hormone therapypsychoneuroendocrinologygynecologycognitive impairmentpostmenopausal womenendocrinologyhealth sciences

(054) Optimizing Internet-Based Psychosocial Intervention for Breast Cancer-Related Sexual Morbidity: Protocol for a Factorial Trial. The Journal of Sexual Medicine (2024)

K ShafferJ ReeseE V DresslerW CohnJ V GlazerC FrederickS ShowalterA H ClaytonM LochS C DanhauerL CollinsK E WeaverG J LesserL Ritterband

medical internet researchconnected healthbreast cancerehealthhealth sciencespublic healthinternet-based psychosocial interventiontelehealthsexual medicinesexual healthfactorial trialhealth communicationdigital healthtreatment planninghealth technologypatient-reported outcomesdigital interventionsmedicineclinical researchdigital medicine

Abstract Ps06-02: Circulating Tumor Dna (Ctdna) Monitoring of Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (Er+/Her2-) High Risk Breast Cancer During Adjuvant Endocrine Therapy. Cancer Research (2024)

Lajos PusztaiEkaterina KalashnikovaEvthokia HobbsUrsa Brown-GlabermanMonica MitaPaula KleinFengting YanSima EhsaniWajeeha RazaqAlison StopeckManali BhaveMichelle LochSagar SardesaiEvanthia Roussos TorresMark BurkardFemi OkubanjoEric GauthierAngel RodriguezMinetta LiuPeter Kabos

gynecologic oncologypharmacologybreast cancertumor biologycancer researchcancer treatmenthealth sciencesradiation oncologyendocrine oncologymedicinal researchmolecular diagnosticscancer riskcancer carecancer managementtumor targetingadjuvant endocrine therapycirculating tumor dnacancer imagingclinical researchoncology

A Single-Center Retrospective Review of the Impact of Cryotherapy on Peripheral Neuropathy Scores in Patients With Breast Cancer Who Received Chemotherapy With a Taxane-Based Treatment Regimen.. Journal of Clinical Oncology (2024)

Deanna HuffmanAustin PrimeauxElizabeth Reilly HelmLily Zhiying ChenJoseph MasonRafael Guzman-ArevaloAndrew G ChappleMichelle Marie Loch

neurologyradiation oncologysingle-center retrospective reviewperipheral neuropathy scorescancer researchmedicinetaxane-based treatment regimenclinical researchcancer treatmentcancer careoncologybreast cancer

Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the Wf-2202 Sexual Health and Intimacy Enhancement (Shine) Trial. JMIR Research Protocols (2024)

Kelly M ShafferJennifer Barsky ReeseEmily V DresslerJillian V GlazerWendy CohnShayna L ShowalterAnita H ClaytonSuzanne C DanhauerMichelle LochMai KadiCaleigh SmithKathryn E WeaverGlenn J LesserLee M Ritterband

intimacy enhancementinternet-delivered interventionsexual healthhealth sciencesfactorial trial

Interim Safety Analysis of Phase Ib Trial of Her2 Inhibitor Tucatinib Combined With Pi3Kα Inhibitor Alpelisib in Her2+ Pik3Ca -Mutated Metastatic Breast Cancer.. Journal of Clinical Oncology (2024)

breast oncologyoncogenesmetastasisphase ib trialanti-cancer agentsmolecular cancerinterim safety analysispharmacologymedicinemetastatic breast cancerpharmacotherapycancer treatmentcancer careoncologybreast cancer

1
2
3
4
10 / page

Michelle Loch

Louisiana State University Health Sciences Center, New Orleans

Affiliations

School of Medicine

Division of Hematology & Oncology

NoneMichelle Loch is currently serving as a Division Of Hematology & Oncology faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michelle Loch

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract P1-10-19: Hypophysitis and Haziness in Her2: A Case of Breast Cancer With Leptomeningeal Carcinomatosis. Clinical Cancer Research (2025)

pathologyleptomeningeal carcinomatosisgynecologyabstract p1-10-19breast cancer

Abstract P4-03-06: A Single-Center Review of the Impact of an Integrated Women’s Health Clinic for Breast Cancer Patients Who Received Cancer-Directed Treatment. Clinical Cancer Research (2025)

breast oncologygynecologic oncologywomen's healthhealth clinicgynecologybreast cancer patientsnursingsingle-center reviewcancer managementcancer careoncologybreast cancer

Abstract P5-03-10: Safety and Preliminary Efficacy of Tucatinib and Alpelisib in Patients With Her2-Positive Pik3Ca-Mutated Metastatic Breast Cancer. Clinical Cancer Research (2025)

breast oncologyoncogenesmetastasisradiation oncologypreliminary efficacymolecular cancerabstract p5-03-10pharmacologycancer treatmentcancer careoncologybreast cancer

Circulating Tumor (Ct)Dna Monitoring of Er+/Her2- High-Risk Breast Cancer During Adjuvant Endocrine Therapy.. Journal of Clinical Oncology (2025)

breast oncologypathologyendocrine-related cancersadjuvant endocrine therapyradiologycancer imagingcancer detectiondna monitoringcancer cellscancer treatmentcancer careoncologybreast cancer

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women. JAMA Oncology (2025)

(054) Optimizing Internet-Based Psychosocial Intervention for Breast Cancer-Related Sexual Morbidity: Protocol for a Factorial Trial. The Journal of Sexual Medicine (2024)

K ShafferJ ReeseE V DresslerW CohnJ V GlazerC FrederickS ShowalterA H ClaytonM LochS C DanhauerL CollinsK E WeaverG J LesserL Ritterband

Deanna HuffmanAustin PrimeauxElizabeth Reilly HelmLily Zhiying ChenJoseph MasonRafael Guzman-ArevaloAndrew G ChappleMichelle Marie Loch

intimacy enhancementinternet-delivered interventionsexual healthhealth sciencesfactorial trial

1
2
3
4
10 / page